PFMOSF
ANRO icon

Philadelphia Financial Management of San Francisco’s Alto Neuroscience ANRO Stock Holding History

Philadelphia Financial Management of San Francisco’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-449,952
Closed -$5.15M – 64
2024
Q3 		$5.15M Buy
449,952
+6,663
+2% +$81.5K 0.82% 35
2024
Q2 		$4.74M Buy
443,289
+7,800
+2% +$102K 0.83% 36
2024
Q1 		$6.68M Buy
+435,489
New +$6.82M 1.14% 36

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Philadelphia Financial Management of San Francisco's ANRO Position: Q4 2024 in Review

Philadelphia Financial Management of San Francisco sold out of Alto Neuroscience (ANRO) in Q4 2024, closing a stake of 449,952 shares — an estimated $5.15M sold.

Philadelphia Financial Management of San Francisco first reported a position in ANRO in Q1 2024 and held it in 3 quarters. The position peaked at $6.68M in Q1 2024. 77 funds tracked by Wall St. Rank hold ANRO as of Q4 2024.

  • Philadelphia Financial Management of San Francisco reported no remaining Alto Neuroscience position as of Q4 2024 after selling out during the quarter.
  • Philadelphia Financial Management of San Francisco sold 449,952 Alto Neuroscience shares in Q4 2024, an estimated $5.15M.
  • Philadelphia Financial Management of San Francisco first reported a position in Alto Neuroscience in Q1 2024 and held it in 3 quarters.
  • Philadelphia Financial Management of San Francisco's Alto Neuroscience position peaked at $6.68M in Q1 2024.
  • 77 funds tracked by Wall St. Rank held Alto Neuroscience as of Q4 2024.

Based on Philadelphia Financial Management of San Francisco's 13F filing for Q4 2024, filed 14 Feb 2025.